We are live on ! Find out more
AAM

Ardevora Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 26.09%
This Fund
S&P 500
This Quarter Est. Return
+31.72%
1 Year Est. Return
+26.09%
3 Year Est. Return
+39.37%
5 Year Est. Return
+181.14%
10 Year Est. Return
AUM
$5.11B
AUM Growth
+$1.34B
Cap. Flow
+$307M
Cap. Flow %
6.02%
Top 10 Hldgs %
10.52%
Holding
129
New
22
Increased
39
Reduced
56
Closed
12

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$46.3M
2
CSCO icon
Cisco
CSCO
+$43.8M
3
AZO icon
AutoZone
AZO
+$42.5M
4
LIN icon
Linde
LIN
+$42.3M
5
HSIC icon
Henry Schein
HSIC
+$42M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$64.5M
2
DG icon
Dollar General
DG
+$57.3M
3
MSCI icon
MSCI
MSCI
+$55.2M
4
TEAM icon
Atlassian
TEAM
+$48.7M
5
RGEN icon
Repligen
RGEN
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 24.39%
2 Healthcare 16.19%
3 Industrials 14.76%
4 Consumer Discretionary 13.07%
5 Communication Services 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
126
Sysco
SYY
$40.8B
-614,996
Closed -$28.1M
TEAM icon
127
Atlassian
TEAM
$25.6B
-355,000
Closed -$48.7M
TXRH icon
128
Texas Roadhouse
TXRH
$13.5B
-853,093
Closed -$35.2M
TWTR
129
DELISTED
Twitter, Inc.
TWTR
-1,234,316
Closed -$30.3M

Similar funds

Ardevora Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Ardevora Asset Management held 129 positions worth $5.11B, up 35% from $3.77B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Ardevora Asset Management deployed $307M of net new capital in Q2 2020, opening 22 new positions and adding to 39 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was DexCom, an estimated $64.5M trimmed.

  • Ardevora Asset Management's largest Q2 2020 buy was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.
  • Ardevora Asset Management added most to ResMed in Q2 2020, an estimated $40.7M increase.
  • Ardevora Asset Management's biggest Q2 2020 reduction was DexCom, cutting an estimated $64.5M.
  • Ardevora Asset Management fully exited Atlassian in Q2 2020, selling an estimated $48.7M.
  • Ardevora Asset Management's ten largest holdings make up 11% of its $5.11B portfolio in Q2 2020.
  • Ardevora Asset Management opened 22 new positions and closed 12 in Q2 2020.
  • Ardevora Asset Management's portfolio value rose 35% quarter-over-quarter to $5.11B.

Based on Ardevora Asset Management's 13F filing for Q2 2020, filed 28 Jul 2020.